Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.68    0.03 (0.65%)
Bid:
4.61
Ask:
4.695
Spread: 0.085 (1.844%)
Market Cap: £224.62m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

AGM Statement

27 Nov 2012 07:01

RNS Number : 0347S
Seeing Machines Limited
27 November 2012
 



 

Seeing Machines Limited

("Seeing Machines" or the "Company")

 

AGM Statement

 

Seeing Machines, the AIM-listed technology company with a focus on vision based human machine interfaces, will tomorrow hold its Annual General Meeting in Canberra, Australia at the Clifton Suites on Northbourne, 100 Northbourne Ave, Canberra ACT 2601, at 5.00pm AEDT.

 

The Chairman, Terry Winters, will provide the following statement at the meeting:

"The Directors believe that the combination of eye and gaze tracking with facial interpretation will be at the core of future waves of technology and applications in computing and entertainment. We believe this will provide significant opportunities, as well as challenges, for Seeing Machines in the future as we increase our R&D effort to achieve a market leading capability.

 

"Seeing Machines also continues to win new business, most significantly within the Driver Safety Solution (DSS) business. This represents a significant vote of confidence in the capabilities of our revamped sales force and refocused products."

 

Commenting on these latest developments, Chief Executive Officer, Ken Kroeger, will make the following remarks:

"DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment. We anticipate sales of DSS will grow over the next 18 months as pressure on companies to monitor and manage these risks intensifies.

 

"As well as selling the DSS units, we derive revenue from recurring maintenance, support services and specialist fatigue management consulting, data management, analysis and reporting services. A particular focus for us going forward will be on growing our services income through the DSSi management reporting suite. We see this as a way to enhance our client relationships and improve the quality of earnings, revenue visibility and gross margins."

 

Closing the meeting, Terry Winters will conclude:

"I am pleased to report that in line with the statement made with the preliminary results in September, the first few months of the current financial year commencing 1 July 2012 have shown further strengthening of the Company's sales pipeline. I am therefore very pleased to report the Board is confident in the outlook for the current financial year and beyond."

 

A copy of the slide presentation to made at the Annual General Meeting will be made available on the Company's website: www.seeingmachines.com

 

Enquiries:

 

Seeing Machines Limited

Terry Winters (Chairman)

Ken Kroeger (Managing Director & CEO)

 

+61 (0) 411 411 111

+61 (2) 6103 4700

 

finnCap Ltd

 

Ed Frisby/Ben Thompson (Corporate Finance)

Simon Starr (Corporate Broking)

+44 (0) 20 7220 0500

Walbrook PR Ltd

Helen Westaway (Media Enquiries)Paul Cornelius (Investor Enquiries)

+44 (0) 20 7933 8780

 

 

About Seeing Machines Limited

Seeing Machines is a world leader in the development of premier products and applications that rely on capturing and understanding the behaviour of human faces and eyes. More information is available from our web site: www.seeingmachines.com

About Seeing Machines' Driver Safety Solution (DSS)

The Seeing Machines DSS suite is a rugged, non-invasive platform that uses cutting edge face and eye tracking techniques to deliver information on operator fatigue and distraction. The DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment and therefore need to be monitored and managed.

For more information on DSS, go to http://www.seeingmachines.com/product/dss/

About Seeing Machines' Fatigue Management Consulting

Seeing Machines supports its DSS technology with professional and scientific fatigue management consulting and training services designed to build understanding of how businesses can reduce the risk of operator fatigue and support the readiness, implementation and acceptance of its products. Seeing Machines has developed a comprehensive fatigue management framework through combined collaboration with leading fatigue research institutions and hands on experience in the field with organisations who proactively manage fatigue. Seeing Machines also provides detailed fatigue management training for site personnel to better enable them to understand the causes of, and manage their own fatigue. For more information on fatigue management, go to http://www.seeingmachines.com/fatigue-consultancy/

 

About Seeing Machines' faceAPI®

faceAPI® allows users to incorporate Seeing Machines world-class face tracking technology into their own products or applications. faceAPI provides a growing suite of image-processing modules created specifically for tracking and understanding faces and facial features. These powerful tracking modules are combined into a complete API toolkit that delivers a rich stream of information that can be incorporated into our customers' own products or services. Seeing Machines faceAPI® delivers a comprehensive, integrated solution for developing products that leverage real-time face tracking. All image-processing for face tracking is handled internally, removing the need for computer vision experience. For more information on faceAPI®, go to http://www.seeingmachines.com/product/faceapi/

About Seeing Machines' faceLAB®5

Seeing Machines has been creating advanced eye tracking algorithms since the company was founded in 2000. faceLAB®5 is the organisation's eye tracking system that allows researchers to objectively measure human behavior in a wide range of operational conditions and research settings. faceLAB®'s unique eye and facial tracking solution offers users rare flexibility, portability, and accuracy. For more information on faceLAB®, go to http://www.seeingmachines.com/product/facelab/

About Seeing Machines' Truefield® Analyzer (TFA)

Currently going through its final clinical trials, the TFA will make objective visual field testing a clinical reality. It combines objectivity with 'non-contact' ease of use, making it easy for technicians and patients, giving clinicians objectivity when assessing their patients' conditions. Assessing both eyes concurrently, TFA tests are fast and can be run in both full-test and screening modes. The tests' bilateral concurrency allows the consensual light reflex to be exploited to identify bilateral asymmetries improving test accuracy. Most importantly, the TFA makes objective perimetry a clinical reality. For more information on TFA, go to http://www.seeingmachines.com/product/truefield/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBKADDABDDBDB
Date   Source Headline
6th Jun 201912:53 pmRNSHolding(s) in Company
5th Jun 20191:03 pmRNSSenior Leadership Transition
16th May 20197:00 amRNSFleet Update
30th Apr 20192:58 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirectorate Change
25th Apr 201910:18 amRNSHolding(s) in Company
23rd Apr 20198:34 amRNSResult of GM, Offer and Total Voting Rights
10th Apr 20197:00 amRNSAutomotive deal with Joyson for US OEM
5th Apr 20197:00 amRNSSeeing Machines partners with Australian insurer
2nd Apr 201912:01 pmRNSIssue of Equity and Total Voting Rights
25th Mar 20192:00 pmRNSPosting of Offer Documents & Notice of GM
22nd Mar 20197:00 amRNSSubscription by Directors & Senior Management
20th Mar 201911:35 amRNSConditional Placing & Subscription to raise £27.5m
20th Mar 201911:29 amRNSHalf-year Report to 31 December 2018
8th Mar 20197:00 amRNSEye tracking technology trial with Toll
22nd Feb 20198:30 amRNSEU mandates safety technology for vehicles
19th Feb 20197:00 amRNSSixth Automotive OEM Design Win
16th Jan 20197:00 amRNSHalf year trading update
14th Jan 20197:00 amRNSCadillac Super Cruise 2019 Technology of the Year
13th Dec 20187:00 amRNSBoard Changes
12th Dec 20187:00 amRNSCollaboration with L3 to deliver eye tracking
6th Dec 20182:33 pmRNSIssue of Shares and Total Voting Rights
3rd Dec 20187:00 amRNSLuke Oxenham appointed Chief Financial Officer
26th Nov 20187:00 amRNSAviation division signs deal with Air Force
23rd Nov 20187:00 amRNSChief Financial Officer
16th Nov 20187:00 amRNSAppoints Paul McGlone to head Fleet division
14th Nov 20187:00 amRNSResult of AGM
14th Nov 20187:00 amRNSAGM Statement
22nd Oct 201810:27 amRNSNotice of AGM
17th Oct 20187:00 amRNSSeeing Machines appoints Ryan Murphy as COO
28th Sep 201811:05 amRNSIssue of Shares
19th Sep 20187:00 amRNSYear end results
11th Sep 20187:00 amRNSSeeing Machines launches Guardian BdMS
4th Sep 20182:06 pmRNSSecond Price Monitoring Extn
4th Sep 20182:00 pmRNSPrice Monitoring Extension
4th Sep 201811:05 amRNSSecond Price Monitoring Extn
4th Sep 201811:00 amRNSPrice Monitoring Extension
4th Sep 201810:19 amRNSSeeing Machines Limited Fleet Business Unit Update
29th Aug 20187:00 amRNSGuardian DMS covers more than 1 billion km
23rd Aug 201812:02 pmRNSTransfer of Ordinary Shares
16th Aug 201811:09 amRNSHolding(s) in Company
15th Aug 20189:41 amRNSIssue of Shares for Vested Performance Rights
9th Aug 20187:00 amRNSSeeing Machines leads pilot training collaboration
3rd Aug 20187:00 amRNSYear end trading update
27th Jul 20187:00 amRNSOEM Design Award
16th Jul 20187:00 amRNSBoard changes
5th Jul 20187:00 amRNSUS Fleet (Guardian) Contract
28th Jun 20181:27 pmRNSHolding(s) in Company
15th Jun 201810:43 amRNSKey Staff Recognised
7th Jun 201811:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.